TRANSVAC-DS logo_200714.png
  • LinkedIn
  • Twitter
nick-fewings-zF_pTLx_Dkg-unsplash_edited

About TRANSVAC-DS

Towards a sustainable vaccine infrastructure

 

Through the TRANSVAC infrastructure, state-of-the-art scientific-technical services, technical training, and innovative research and development are currently providing very significant support to European vaccine researchers and developers.

TRANSVAC-DS builds on the outstanding success and lessons learned from TRANSVAC and during the two-year project duration will further explore and prepare the establishment of a stable and truly sustainable European vaccine infrastructure. The main objective and output of TRANSVAC-DS is the preparation of a conceptual design report that will describe in detail the maturity of the vaccine infrastructure concept and be the basis for the establishment of a permanent and sustainable vaccine infrastructure of direct relevance to and benefit for Europe and further afield. As part of the design report, a five-year business plan will be delivered together with an implementation plan that will guide the further establishment of a sustainable European vaccine infrastructure.

 

Coordination teamEuropean Vaccine Initiative

Hilde Depraetere 

Stefan Jungbluth 

Project management team

Monika Slezak

Catarina Luís

flag_yellow_low.jpg

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 951668.

Apply for Vaccine R&D services and Training:

flag_yellow_low.jpg

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 951668.

TRANSVAC-DS logo_white_200714.png

© 2021 European Vaccine Initiative. Designed by European Vaccine Initiative